Sonnet BioTherapeutics Holdings, Inc. (SONN)

Stock Price Forecast

According to 8 stock analysts, the average 12-month stock price forecast for SONN stock is $2.3, which predicts an increase of 721.43%. The lowest target is $2.02 and the highest is $2.63. On average, analysts rate SONN stock as a buy.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.02	$2.3	$2.3	$2.63
Change	+621.43%	+721.43%	+721.43%	+839.29%

Analyst Ratings

The average analyst rating for SONN stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '22	Feb '22	Mar '22	Apr '22	May '22	Jun '22
Strong Buy	3	3	3	3	3	3
Buy	5	5	5	5	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	8	8

Financial Forecast

Revenue This Year

204.00K

from 483.63K

Decreased by -57.82%

from 483.63K

Revenue Next Year

n/a

from 204.00K

from 204.00K

EPS This Year

-0.47

from -1.02

from -1.02

EPS Next Year

-0.40

from -0.47

from -0.47

Year	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	41.43M	30.73M	-	-	483.63K	204.00K	-	-	-	-
Revenue Growth	-0.65%	-25.82%	-	-	-	-57.82%	-	-	-	-
EPS	-70.98	-51.48	-0.91	-6.96	-1.02	-0.47	-0.40	-0.51	-0.47	-0.44
EPS Growth	-	-	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	4	2	2

Revenue Forecast

Revenue	2022	2023	2024	2025	2026
High	210,000	n/a	n/a	n/a	n/a
Avg	204,000	n/a	n/a	n/a	n/a
Low	196,000	n/a	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2022	2023	2024	2025	2026
High	-	-	-	-	-
Avg	-	-	-	-	-
Low	-	-	-	-	-

EPS Forecast

EPS	2022	2023	2024	2025	2026
High	-0.45	-0.26	-0.53	-0.49	-0.46
Avg	-0.47	-0.40	-0.51	-0.47	-0.44
Low	-0.49	-0.53	-0.49	-0.46	-0.43

EPS Growth

EPS Growth	2022	2023	2024	2025	2026
High	-	-	-	-	-
Avg	-	-	-	-	-
Low	-	-	-	-	-